Celltrion Projects First-Ever 1 Trillion-Won Annual Operating Profit for 2025
Seoul: Celltrion Inc., a major South Korean biopharmaceutical company, announced its expectations for its annual operating profit to surpass 1 trillion won (US$693 million) for